HomeHome SearchSearch MenuMenu Our productsOur products Who we areWho we are

Diabetes mellitus medicine can reduce your Parkinson's disease risk by 35%

by , 04 October 2017
Diabetes mellitus medicine can reduce your Parkinson's disease risk by 35%
Medicinal treatment against diabetes mellitus may reduce your risk of getting Parkinson's disease by 35%. This is according to a study conducted by researchers at the Department of Clinical Medicine at the University of Bergen in Norway.

“We've made an important discovery, which takes us a step further towards solving the Parkinson's riddle,” said researcher Charalampos Tzoulis who led the study together with researcher Kristoffer Haugarvoll from the same department. Keep reading for the full findings…

Breakthrough: Norwegian study finds that diabetes mellitus medicine may reduce risk of Parkinson’s disease

To reach these findings, the two researchers analysed and compared data from the Norwegian Prescription Base. The database has information on all use of prescription over the last 10 years. All in all, it contains data on more than 100m prescriptions.
The researchers found a link between diabetes mellitus medicine and a 35% lower risk of Parkinson’s disease – a disorder of the central nervous system that affects movement, often including tremors. They believe that the diabetes mellitus medicines, which contain so-called glitazones, stimulate the cells to produce more mitochondria – the powerhouse of the cells responsible for transforming nutrients that cells need to work and creating 90% of the energy needed to sustain life and support organs.


Blood sugar worries? 
Get ready to sigh with sweet relief!
When this research first crossed my desk I couldn’t believe it!
The latest blood sugar science shows that your body’s own safety mechanism is why your current blood sugar solution may be selling you short.
In fact, this research confirms that targeting only your body’s natural insulin and your pancreas to conquer blood sugar is like trying to douse a forest fire with a glass of water.
But this research has also led to some really exciting news for you—a breakthrough in blood sugar science that no one saw coming.
Get ready to sigh with sweet relief!

Tzoulis noted that he and his research group had previously found that the production of mitochondria decreases during Parkinson’s disease.

Follow-up studies are needed to better understand the link between diabetes mellitus medicine and Parkinson’s disease

Tzoulis concluded that researchers need to go one step further and do follow-up studies on diabetes medicines to better understand how it protects against Parkinson’s disease. “If we understand the mechanisms behind the protection, then we have a chance to develop a new treatment.”
Keep your eyes open for more news on diabetes mellitus medicine as a potential Parkinson’s disease treatment!

Vote article

Diabetes mellitus medicine can reduce your Parkinson's disease risk by 35%
Note: 5 of 1 vote

Related articles

Related articles


Health Solutions